Nobel Prize Winning Economist Trashes Pharmaceutical Patents
from the continuing-the-trend dept
Continuing last week's discussion about why patents may be bad for the pharmaceutical industry (the one industry that even those who hate other types of patents often agree patents are needed), Slashdot points us to an editorial by Nobel Prize winning economist Joseph Stiglitz where he writes eloquently on the problems associated with pharmaceutical patents. It covers much of the same ground that we've discussed here in the past, but is absolutely worth reading. He covers Thomas Jefferson's view of intellectual monopolies, and how they only make things inefficient. He discusses the tradeoffs associated with stimulating new drugs, but then notes that the costs appear to greatly outweigh the benefits:"Research needs money, but the current system results in limited funds being spent in the wrong way. For instance, the human genome project decoded the human genome within the target timeframe, but a few scientists managed to beat the project so they could patent genes related to breast cancer. The social value of gaining this knowledge slightly earlier was small, but the cost was enormous. Consequently the cost of testing for breast cancer vulnerability genes is high. In countries with no national health service many women with these genes will fail to be tested. In counties where governments will pay for these tests less money will be available for other public health needs.Stiglitz alternative is to use a bounty system that would set up prize money for important pharmaceutical cures and breakthroughs, on the condition that the details of the drugs would then be available to other drugmakers to create generic versions and let the market set the price. It's an idea that has certainly been suggested before, and does present some additional problems (what gets a prize, how big are the prizes, where is the money coming from?), but given how screwed up the existing system is, it's an idea that's at least worth discussing.
![Hide This Hide this](https://ii.techdirt.com/s/t/i/topclose.png)
Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.
While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.
–The Techdirt Team
Reader Comments
Subscribe: RSS
View by: Time | Thread
Government contracts
Not to say the patent system perhaps shouldn't be visited upon for discussion, but I don't see why there has to be socialist-style, deep market intervention that would fundamentally try to change the game. Such things always sound good and have good intentions but seldom seem to work, right?
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Human Genome is Pharmaceutical?!?
Ultimately millions are being spent on pharmaceutical research – most of which leads to nothing of value. When a successful drug does materialize (and makes it through the long and expensive FDA approval cycle), it also has to pay for the hundreds, if not thousands, of failures.
Setting up prize money will only have governments directing which things should be researched; things that may make money, but having neither prize money nor possible patent protection won’t come to market. Viagra ultimately is a failed heart medication and it’s success justified/justifies the research into heart medications.
If I was running a pharmaceutical company and the government decided to go this route, I would immediately cut back my R&D effort – if not eliminate it – and set about to clone the successful drugs that win government backing. That way you’re guaranteed to make money without having the risk of R & D.
[ link to this | view in chronology ]
Re: Human Genome is Pharmaceutical?!?
So you see patenting genes has EVERYTHING to do with the pharmaceutical industry.
[ link to this | view in chronology ]
Re: Re: Human Genome is Pharmaceutical?!?
Thank you for explaining my point for me. What you're effectively saying is that if I patent a software virus (human genome) I can sue the anti-virus companies (RNA blockers) for detecting my virus. Sorry, that’s a misapplication of the patent.
The patent holder for the human genome would either have to sue God or parents who use his "invention" without their permission.
Using an obvious gross misapplication of the patent system in order to brush away the entire system is disingenuous.
[ link to this | view in chronology ]
It just won't work...
The whole point of the theory is to make generics readily available, and a lot of attention was paid in the article to getting generics to those who couldn't afford name brand meds, yet the countries with lots of people that CAN afford name brand meds are going to pay for these "bounties" for achievement? I can hear the cries of "why should I pay for their medicine" (although we do now anyway by generating most of the profits for drug companies, but people won't see it that way).
Not to beat a dead horse here but the proposed system would be extremely expensive to implement and all of that burden would be placed on a small fraction of governments to pay for it. In addition to that, the motivation (profits) for pharmaceutical companies to perform a wide array of research would be nullified and they will become like defense contractors in most cases, doing stuff to meet government specs and get money, not necessarily the things thats best for development (look up the history of the development of the bradley fighting vehicle or the F15 fighter plane).
The issue isn't with patents per-se, but with the standards that currently exist for getting one. I say more effort needs to be made on an industry by industry basis to develop guidelines for patent approval that protect novel ideas and at the same time protect against monopolies/obvious patents. Durations of patents should be industry specific and perhaps there should be multiple tiers based on the type of patent (a seldom used med may have a longer patent than a frequently used one, to allow more time to recoup R&D costs and also to stimulate companies to not set the prices so high).
The fundamental problem in the pharmaceutical industry is that there is very little reason to develop cures for illnesses in general, and illnesses that very few people get in particular. You can make lots of money with an effective "treatment" for high blood pressure, but not nearly as much if you figure out a way to cure it with a pill (unless the pill is like $10,000 each), and even less if you develop a pill to treat/cure an illness like polio, which is very rare in the modern age but there is a case from time to time in recent history. The point is that maintenance and "life-style" meds are the bread and butter of the pharmeceutical industry and maybe that is where the efforts to "fix" the system should be. This is one area where maybe the bounty system would be mildly useful (to research areas that don't, and never will, have a potential big monetary payoff). On the other hand, I think the money may be better served by just assigning government agencies like the NIH the task of solving rare diseases and finding cures rather than treatments for common ailments
As per access to medications in the third world, a lot of countries have kind of taken the "mp3" view of generics. They make and distribute copies of the name brands without permission from the pharmaceutical companies. While I'm a strong opponent to doing this to movies and music, for life saving medications perhaps doing the Robin Hood thing is the way to go. On paper we all look like we play together and patents are truly worldwide, in reality the sick people get what they need at an affordable price. Seems to me that's the only way to solve the problem, plausible deniability/looking the other way.
[ link to this | view in chronology ]
Re: It just won't work...
a) Bounties in general = dismal idea. Bounties on cures, on the other hand, might encourage developments.
b) Third world countries illegally producing medicine is breaking the law, yeah. But the industrial world probably doesnt lose much money over it, and once those countries start to ascend the economic ladder, they'd either voluntarily or be forced to crack down on those things once they could afford to anyway.
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Bounty for innovation
[ link to this | view in chronology ]